期刊文献+

STK15基因多态性与膀胱癌发病风险的关系 被引量:2

Association between STK15 genetic polymorphism and risk of bladder cancer
下载PDF
导出
摘要 目的探讨STK15Phe31Ile基因单核苷酸多态与膀胱癌风险的关系。方法采用病例对照研究方法,以聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术,检测60例膀胱癌患者和60例正常对照者STK15Phe31Ile基因型,比较不同基因型与膀胱癌危险性及其病理特征的关系。结果 STK15Phe31Ile三种基因型(Phe/Phe、Phe/Ile、Ile/Ile)在病例组的分布频率分别为20%、25%和55%,在对照组分别为28.3%、41.6%和30%,分布差异具有统计学意义(P=0.021)。携带STK15Ile/Ile基因型者患膀胱癌的风险比携带STK15Phe/Phe基因型者增加159%(OR=2.59,95%CI=1.019~6.622),此种风险增加在吸烟患者中更为显著(OR=5.33,95%CI=1.282~22.192)。未发现STK15Phe31Ile基因多态与膀胱癌病理特征相关。结论 STK15Phe31Ile基因多态可能是膀胱癌的遗传易感因素。 Objective To detect the association between STK15 Phe31 Ile polymorphism and risk of bladder cancer. Methods In a case-control study,genotypes of STK15 Phe31 Ile were determined by PCR-RLFP in 60 patients with bladder cancer and 60 controls. Their association with bladder cancer risk and pathological outcome were analyzed. The adjusted odds ratios (ORs)and 95% confidence intervals (CIs)were calculated using logistic regression model. Results The frequency of the three genotypes (Phe/Phe, Phe/Ile and Ile/Ile) of STK15 Phe31 Ile in bladder cancer patients was 20%, 25% and 55% respectively, which was significantly different from that in the controls (28.3 %, 41.6 % and 30 % ) (P : 0. 021 ). Subjects with the Ile/Ile genotype had an increased risk for the occurrence of bladder cancer compared with those with the Phe/Phe genotype ( OR : 2.59,95 % CI =1. 019 - 6. 622). The risk was more significant in the subjects who smoked( OR : 5.33,95 % CI : 1. 282 -22. 192). No significant association was observed between the STK15 polymorphism and bladder cancer pathological outcome. Conclusion Our study suggestes that STK15 Phe31 Ile polymorphisms are likely to be associated with an increased risk of bladder cancer in Chinese people. Confirmation of this study is needed in a larger case-control population.
出处 《现代泌尿外科杂志》 CAS 2010年第4期277-279,共3页 Journal of Modern Urology
基金 北京市自然科学基金资助项目(No.7052025)
关键词 膀胱癌 STK15 基因多态性 bladder tumor STK15 polymorphism
  • 相关文献

参考文献10

  • 1FRANEKOVA M, HALASOVA E, BUKOVSKA E, et al. Gene polymorphisms in bladder cancer[J]. Urol Oncol, 2008,26 (1) : 1-8.
  • 2ZHOU H, KUANG J, ZhONG L, et al. Tumour amplified kinase STK15 /BTAK induces centrosome amplification, aneuploidy and transformation[J]. Nat Genet, 1998,20(2) : 189-193.
  • 3EWARTTOLAND A, BRIASSOULI P, DE KONING JP, et al. Identification of STK6/STK15 as a candidate low-penetrance tumorsusceptibility gene in mouse and human[J]. Nat Genet, 2003,34 (4) : 403-412.
  • 4MIAO X,SUN T,WANG Y,et al. Functional STK15 Phe31 lie polymorphism is associated with the occurrence and advanced disease status of esophageal squamous cell carcinoma[J]. Cancer Res, 2004, 64(8) : 2680-2683.
  • 5张雯杰,缪小平,孙瞳,张雪梅,曲世宁,谭文,熊萍,郑容,林东昕.STK15基因单核苷酸多态与大肠癌风险[J].中华肿瘤杂志,2006,28(1):43-46. 被引量:7
  • 6SEN S, ZHOU H, ZHANG RD, et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer[J].J Natl Cancer Inst,2002,94(17) : 1320-1329.
  • 7SCHULTZ IJ,KIEMENEY LA,ROELOFS R,et al. The prognostic role of the STK15 TglA polymorphism and of STK15 mRNA expression in patients with urothelial cell carcinoma[J].Anticancer Res. 2007,27 (2) : 1025-1030.
  • 8WANG R,WANG JH,CHU XY,et al. Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance[J]. Chn Biochem. 2009,42(7-8) :641-647.
  • 9CHEN SS, CHANG PC, CHENG YW, ct al. Suppression of the STK15 oncogcnic activity requires a transactivation-independent P53 function[J]. EMBO J,2002,21(17) : 4491-4499.
  • 10HAMMERSCHMIED CG,STOEHR R,WALTER B,et al. Role of the STK15 Phe31Ile polymorphism in renal cell carcinoma. Oncol Rep[J]. 2007,17(1):3-7.

二级参考文献10

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Lengauer C,Kinzler KW,Vogelstein B.Genetic instability in colorectal cancers.Nature,1997,386:623-627.
  • 3Zhou H,Kuang J,Zhong L,et al.Tumour amplified kinase STK15/BTAK induces centrosome amplification,aneuploidy and transformation.Nat Genet,1998,20:189-193.
  • 4Bischoff JR,Anderson L,Zhu Y,et al.A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers.EMBO J,1998,17:3052-3065.
  • 5Ewart-Toland A,Briassouli P,de Koning JP,et al.Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human.Nat Genet,2003,34:403-412.
  • 6Miao X,Sun T,Wang Y,et al.Functional STK15 Phe31Ile polymorphism is associated with the occurrence and advanced disease status of esophageal squamous cell carcinoma.Cancer Res,2004,64:2680-2683.
  • 7Hidaka S,Yasutake T,Takeshita H,et al.Differences in 20q13.2copy number between colorectal cancers with and without liver metastasis.Clin Cancer Res,2000,6:2712-2717.
  • 8Moreno-Bueno G,Sanchez-Estevez C,Cassia R,et al.Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma:STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.Cancer Res,2003,63:5697-5702.
  • 9Shackney SE,Shankey TV.Common patterns of genetic evolution in human solid tumors.Cytometry,1997,29:1-27.
  • 10Sen S,Zhou H,Zhang RD,et al.Amplification/overexpression of a mitotic kinase gene in human bladder cancer.J Natl Cancer Inst,2002,94:1320-1329.

共引文献6

同被引文献50

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部